2 completed. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
Follow INO-4500: new trials by email Literature Review of INO-4500 trials Research Report on INO-4500
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Dose-ranging Study: Safety, Tolerability and Immunogenicity of INO-4500 in Healthy Volunteers in Ghana INO-4500, CELLECTRA™ 2000, Placebo - Lassa Fever | Phase 1 | Completed | Inovio Pharmaceuticals | 220 | 2021-01-27 | 2022-11-21 |
| Safety, Tolerability and Immunogenicity of INO-4500 in Healthy Volunteers INO-4500, Placebo, CELLECTRA® 2000 - Lassa Fever | Phase 1 | Completed | Inovio Pharmaceuticals | 60 | 2019-05-09 | 2020-11-23 |
Lassa Fever (2)
Ghana (1) · United States (1)
Bonaventure Orizu, MD (1) · Mammen Mammen, MD, FACP, FIDSA (1)